Vascular Calcification

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Seventh Edition

Volumn , Issue , 2009, Pages 436-442

  Towler, Dwight A ^a   Demer, Linda L ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80955179635     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470623992.ch93     Document Type: Chapter

References (70)

1. Abedin M, Tintut Y, Demer LL 2004 Vascular calcification:Mechanisms and clinical ramifications. Arterioscler Thromb VascBiol 24:1161-1170.
2. Stary HC. Chandler AB, Dinsmore RE, Fuster V, Glagov S , InsullW Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW 1995 A definition of advanced types of atherosclerotic lesions and ahistological classification of atherosclerosis. A report from theCommittee on Vascular Lesions of the Council on Arteriosclerosis,American Heart Association. Arterioscler Thromb Vasc Riol 15: 1512-1531
3. Newrnan AR, Naydeck BL, Sutton-Tyrrell K. Fcldman A, EdmundowiciD. Kuller LH 2001 Coronary artery calcification in olderadults to age 99: Prevalence and risk factors. Circulation 104:2679-2684.
4. Parhami F, Morrow AD, Balucan J , Leitinger N, Watson AD,Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation productshave opposite effects on calcifying vascular cell and bone cell differentiation.A possible explanation for the paradox of arterialcalcification in osteoporotic patients. Arterioscler Thromb VascBiol 17:680-687.
5. Mohler ER III, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS 2001 Bone formation and inflammation in cardiacvalves. Circulation 103:1522-1528.
6. Virchow R 1863. Cellular Pathology as Based Lipon Physiologicaland Pathological Histology. Dover Publications, New York, NY,USA.
7. Hunt JL, Fairman R, Mitchell ME, Carpentcr JP, Golden M,Khalapyan T, Wolfe M, Neschis D, Milner R, Scoll B, Cusack A,Mohler ER III 2002 Bone formation in carotid plaques: A clinicopathologicalstudy. Stroke 33:1214-1219.
8. Tanimura A, McGregor DH, Anderson HC 1983 Matrix vesiclesin atherosclerotic calcification. Proc Soc Exp Biol Med 172:173-177.
9. Shao JS, Cheng SL, Pingsterhaus JM. Charlton-Kachigian N,Loewy AP, Towler DA 2005 Msx2 promotes cardiovascular calcificationby activating paracrine Wnt signals. J Clin Invest115:1210-1220.
10. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K. Bostrom K,Demer LL 2003 Multilineage potential of cells from the arterywall. Circulation 108:2505-2510.
11. Hu Y, Zhang Z , Torsney E, Afzal AR, Davison F, Metzler B, Xu Q 2004 Abundant progenitor cells in the adventitia contribute toatherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest113:1258-1265
12. Schor AM, Allen TD, Canfield AE, Sloan P, Schor SL 1990 Pericytesderived from the retinal microvasculature undergo calcificationin vitro. J Cell Sci 97:449-461.
13. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, DemerLL 1993 Bone morphogenetic protein expression in human atheroscleroticlesions. J Clin Invest 91: 1800-1809.
14. Garfinkel A. Tintut Y, Petrasek D, Bostrom K, Demer LL 2004Pattern formation by vascular mesenchymal cells. Proc Natl AcadSci USA 101:9247-9250
15. Rattazzi M, Bennett BJ, Bea F, Kirk EA, Ricks JL, Speer M,Schwartz SM, Giachelli CM, Rosenfeld ME 2005 Calcification ofadvanced atherosclerotic lesions in the innominate arteries ofApoE-deficient mice: Potential role of chondrocyte-like cells. ArteriosclerThromb Vasc Biol 25:1420-1425.
16. Morony S, Tintut Y, Zhang Z, Cattley RC, Van G, Dwyer D,Stolina M, Kostenuik PJ, Demer LL 2008. Osteoprotegerin InhibitsVascular Calcification Without Affecting Atherosclerosis inldlr(-/-) Mice. Circulation 117:411-420.
17. Weiss RM, Ohashi M, Miller JD, Young SG, Heistad DD 2006Calcific aortic valve stenosis in old hypercholesterolemic mice.Circulation 114:2065-2069
18. Teivainen PA, Eliassen KA, Berg K, Torsdalen K, Svindland A2004 Atherogenesis and vascular calcification in mice expressingthe human LPA gene. Pathophysiology 11:113-120
19. Demer LL 1991 Effect of calcification on in vivo mechanical responseof rabbit arteries to balloon dilation. Circulation 83:2083-2093.
20. Price PA, Faus SA, Williamson MK 2000 Warfarin-induced arterycalcification is accelerated by growth and vitamin D. ArteriosclerThromb Vasc Biol 20:317-327.
21. Pohle K, Maffert R, Ropers D, Moshage W, Stilianakis N, DanielWG, Achenbach S 2001 Progression of aortic valve calcification:Association with coronary atherosclerosis and cardiovascular riskfactors. Circulation 104:1927-1932.
22. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ 1998 Effectof HMG-CoA reductase inhibitors on coronarv arterv disease asassessed by electron-beam computed tomography. N Engl.J Med339:1972-1978
23. Tintut Y, Patel J, Parhami F, Demer LL 2000 Tumor necrosisfactor-alpha promotes in vitro calcification of vascular cells via theCAMP pathway. Circulation 102:2636-2642.
24. Hirsch D, Azoury R, Sarig S, Kruth HS 1993 Colocalization ofcholesterol and hydroxyapatite in human atherosclerotic lesions.Calcif Tissue Int 52:94-98
25. Boskey AL, Posner AS 1977 The role of synthetic and bone extractedCa-phospholipid-PO4 complexes in hydroxyapatite formation.Calcif Tissue Res 23:251-258
26. Noma A. Takahashi T, Wada T 1981 Elastin-lipid interaction inthe arterial wal. Part 2. In vitro binding of lipoprotein-lipids toarterial elastin and the inhibitory effect of high density lipoproteinson the process. Atherosclerosis 38:373-382.
27. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ,Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM2004 Human vascular smooth muscle cells undergo vesiclemediatedcalcification in response to changes in extracellular calciumand phosphate concentrations: A potential mechanism foraccelerated vascular calcification in ESRD. J Am SOC Nephrol15:2857-2867
28. Nadra I , Mason JC, Philippidis P, Florey O, Smythe CD, McCarthyGM, Landis RC, Haskard DO 2005 Proinflammatory activationof macrophages by basic calcium phosphate crystals via proteinkinase C and MAP kinase pathways: A vicious cycle ofinflammation and arterial calcification'? Circ Res 96:1248-1256
29. Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y,Fukuda D, Nakamura Y, Yamashita H, Yamagishi H, Takeuchi K,Naruko T. Haze K, Becker AE, Yoshikawa J, Ueda M 2004 Spottycalcification typifies the culprit plaque in patients with acute myocardialinfarction: An intravascular ultrasound study. Circulation110:3424-3429.
30. Honye J. Mahon DJ, Jain A, White CJ, Ramee SR, Wallis JB,Al-Zarka A, Tobis JM 1992 Morphological effects of coronary balloonangioplasty in vivo assessed by intravascular ultrasound imaging.Circulation 85:1012-1025
31. Otto CM. Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD1994 Characterization of the early lesion of 'degenerative' valvularaortic stenosis. Histological and immunohistochemical studies.Circulation 90:844-853
32. Katz R, Wong ND, Kronmal R, Takasu J, Shavelle DM, ProbstfieldJL, Bertoni AG, Budoff MJ, O'Brien KD 2006 Features ofthe metabolic syndrome and diabetes mellitus as predictors ofaortic valve calcification in the Multi-Ethnic Study of Atherosclerosis.Circulation 1l3:2113-2119.
33. Vyavahare NR, Jones PL, Hirsch D, Schoen FJ, Levy RJ 2000Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcificationby alcohol pretreatment: Further mechanistic studies. JHeart Valve Dis 9:561-566
34. Rajamannan NM, Subramaniam M, Springett M, Sebo TC,Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO,Spelsberg TC 2002 Atorvastatin inhibits hypercholesterolemiainducedcellular proliferation and bone matrix production in therabbit aortic valve. Circulation 105:2660-2665
35. Rajamannan NM, Subramaniam M, Caira F, Stock SR, SpelsbergTC 2005 Atorvastatin inhibits hypercholesterolemia-induced calcificationin the aortic valves via the Lrp5 receptor pathway. Circulation1l2:1229-1234
36. Ai-Aly Z. Shao JS, Lai CF, Huang E, Cai J, Behrmann A, ChengSL, Towler DA 2007 Aortic Msx2-Wnt calcification cascade isregulated by TNF-alpha-dependent signals in diabetic Ldlr-imice.Arterioscler Thromb Vasc Biol 27:2589-2596
37. Caira FC. Stock SR, Gleason TG, McGee EC, Huang J, BonowRO, Spelsberg TC, McCarthy PM, Rahimtoola SH. RajamannanNM 2006 Human degenerative valve disease is associated withup-regulation of low-density lipoprotein receptor-related protein 5receptor-mediated bone formation. J Am Coll Cardiol 47:1707-1712.
38. Rosenhek R, Binder T, Porenta G, Lang I , Christ G, Schemper M,Maurer G , Baumgartner H 2000 Predictors of outcome in severe,asymptomatic aortic stenosis. N Engl J Med 343:611-617.
39. Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R. Majima K,Aoki T. Nihei H 2004 Effects of cyclic intermittent etidronatetherapy on coronary artery calcification in patients receiving longtermhemodialysis. Am J Kidney Dis 44:680-688.
40. Cowell SJ, Ncwby DE, Prescott RJ, Bloomfield P, Reid J, NorthridgeDB. Boon NA 2005 A randomized trial of intensive hid -lowering therapy in calcific aortic stenosis. N Engl J Med352:2389-2397
41. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF,Rocha-Goncalves F, Rajamannan NM 2007 Rosuvastatin affectingaortic valve endothelium to slow the progression of aortic stenosis.J Am Coll Cardiol 49:554-561.
42. Reaven PD, Sacks J 2005 Coronary artery and abdominal aorticcalcification are associated with cardiovascular disease in type 2diabetes. Diabetologia 48:379-38.
43. Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T,Inaba M. Nishizawa Y 2002 Different risk factors for peripheralvascular calcification between diabetic and non-diabetic haemodialysispatients-importance of glycaemic control. Diabetologia45: 1446-1448.
44. Reynolds JL. Skepper J N , McNair R, Kasama T, Gupta K, WeissbergPL, Jahnen-Dechent W, Shanahan CM 2005 Multifunctionalroles for serum protein fetuin-a in inhibition of human vascularsmooth muscle cell calcification. J Am SOC Nephrol 16:2920-2930.
45. Johnson K, Terkeltaub R 2005 Inorganic pyrophosphate (PPl) inpathologic calcification of articular cartilage. Front Biosci 10:988-997.
46. Lomashvili KA, Khawandi W, O'Neill WC 2005 Reduced plasmapyrophosphate levels in hemodialysis patients. J Am SOC Nephrol16:2495-2500
47. Narisawa, S, Harmey. D, Yadav, MC, O'Neill WC, Hoylaerts MF,Millan JL 2007 Novel inhibitors of alkaline phosphatase suppressvascular smooth muscle cell calcification. J Bone Miner Res22:1700-1710
48. Hsu HH, Camacho NP, Sun F, Tawfik O, Aono H 2000 Isolationof calcifiable vesicles from aortas of rabbits fed with high cholesteroldiets. Atherosclerosis 153:337-348.
49. Shao JS, Aly ZA, Lai CF, Cheng SL, Cai J. Huang E, BehrmannA, Towler DA 2007 Vascular Bmp Msx2 Wnt signaling and oxidativestress in arterial calcification. Ann N Y Acad Sci 1117:40-50.
50. Giachelli CM 2003 Vascular calcification: In vitro evidence for therole of inorganic phosphate. J Am SOC Nephrol 14:S300-S304.
51. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, De Vernejoul MC 2004 Arterial calcifications and bone histomorphometryin end-stage renal disease. J Am Soc Nephrol 15:1943-1951.
52. Raggi P, James G, Burke SK, Bommer J, Chasan-Taber S. Holzer H, Braun J, Chertow GM 2005 Decrease in thoracic vertebralbone attenuation with calcium-based phosphate binders in hemodialysis.J Bone Miner Res 20:764-772
53. Sneddon WB, Magyar CE, Willick GE, Syme CA, Galbiati F,Bisello A, Friedman PA 2004 Ligand-selective dissociation of activationand internalization of the parathyroid hormone (PTH)receptor: Conditional efficacy of PTH peptide fragments. Endocrinology145:2815-2823
54. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC2001 Phenotypic alteration of vascular smooth muscle cells precedeselastolysis in a mouse model of Marfan syndrome. Circ Res88:37-43.
55. Klement JF, Matsuzaki Y, Jiang QJ, Terlizzi J. Choi HY, FujimotoN, Li K, Pulkkinen L, Birk DE, Sundberg JP, Uitto J 2005 Targetedablation of the abcc6 gene results in ectopic mineralizationof connective tissues. Mol Cell Biol 25:8299-8310
56. Essalihi R, Dao HH, Gilberl LA, Bouvet C. Semerjian Y, McKee MD, Moreau P 2005 Regression of medial elastocalcinosis in rataorta: A new vascular function for carbonic anhydrase. Circulation112:1628-1635
57. Price PA, June HH, Buckley JR, Williamson MK 2001 Osteoprotegerininhibits artery calcification induced by warfarin and byvitamin D. Arterioscler Thromb Vasc Biol 21:1610-1616.
58. Davies MR, Lund RJ, Hruska KA 2003 BMP-7 is an efficacioustreatment of vascular calcification in a murine model of atherosclerosisand chronic renal failure. J Am Soc Nephrol 14:1559-1567.
59. Bucay N, Sarosi I , Dunstan CR, Morony S, Tarpley J, CapparelliC, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS1998 Osteoprotegerin-deficient mice develop early onset osteoporosisand arterial calcification. Genes Dev 12:1260-1268
60. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M 1996Medial artery calcification. A neglected harbinger of cardiovascularcomplications in non-insulin-dependent diabetes mellitus. ArteriosclerThromb Vasc Biol 16:978-983
61. London GM, Marchais SJ, Guerin AP, Metivier F 2005 Arteriosclerosis ,vascular calcifications and cardiovascular disease in uremia.Curr Opin Nephrol Hypertens 14:525-531
62. Clarke P, Gray A, Legood R, Briggs A, Holman R 2003 Theimpact of diabetes-related complications on healthcare costs: Resultsfrom the United Kingdom Prospective Diabetes Study(UKPDS Study No. 65). Diabet Med 20:442-450.
63. Phan O, Ivanovski O, Nguyen-Khoa T, Mothu N, Angulo J, Westenfeld R. Ketteler M, Meert N, Maizel J, Nikolov IG, VanholderR, Lacour B, Drueke TB, Massy ZA 2005 Sevelamer preventsuremia-enhanced atherosclerosis progression in apolipoprotein Edeficientmice. Circulation 112:2875-2882.
64. Chertow GM, Burke SK, Raggi P 2002 Sevelamer attenuates theprogression of coronary and aortic calcification in hemodialysispatients. Kidney Int 62:245-252
65. Coates T, Kirkland GS, Dymock RB. Murphy BF, Brealey JK,Mathew TH, Disney AP 1908 Cutaneous necrosis from calcificuremic arteriolopathy. Am J Kidney Dis 32:384-391.
66. Zebboudj AF, Imura M, Bostrom K 2002 Matrix GLA protein, aregulatory protein for bone morphogenetic protein-2. J Biol Chem277:4388-4394.
67. Cicone JS, Petronis JB, Embert CD, Spector DA 2004 Successfultreatment of calciphylaxis with intravenous sodium thiosulfate.Am J Kidney Dis 43:1104-1108
68. Ling Lh, Oh JK, Breen JF, Schaff HV. Danielson GK, Mahoney DW, Seward JB, Tajik AJ 2000 Calcific constrictive pericarditis: Isit still with us'? Ann Intern Med 132:444-450
69. Verma V. Cronin DC II. Dachman AH 2001 Portal and mesenlericvenous calcification in patients with advanced cirrhosis. AJRAm J Roentgenol 176:489-492.
70. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, Weissleder R 2007 Multimodality molecular imagingidentifies proteolytic and osteogenic activities in early aortic valvedisease. Circulation 115:377-386.